Les perspectives thérapeutiques
Hélène Garnier‐Lengliné(Délégation Paris 5), Frank M. Ruemmele(Délégation Paris 5), Nadine Cerf–Bensussan(Université Paris Cité), Georgia Malamut(Délégation Paris 5)
Cited by 1
Related Papers
ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents
|Journal of Pediatric Gastroenterology and Nutrition|2013|1.4k
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
|Journal of Crohn s and Colitis|2014|1.1k
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
|Gastroenterology|2020|692
The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update
|Journal of Crohn s and Colitis|2020|679